EIR Celltrion Pharm Nov 2017

Edmund Mrak FDA$595.00 - Available Now

FDA investigators audited the Celltrion Pharm - Cheongju, Korea (the Republic of) facility and issued inspectional observation (via FDA 483) on 17 Nov 2017.

Product details

  • Category:
  • Inspection end: 17 Nov 2017
  • Location: Cheongju, Korea (the Republic of)
  • FEI: 3012279978
Add To Cart